BOZZATO, DANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.373
AS - Asia 2.615
EU - Europa 1.738
SA - Sud America 576
AF - Africa 534
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 41
AN - Antartide 1
Totale 11.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.020
SG - Singapore 873
CN - Cina 645
BR - Brasile 417
HK - Hong Kong 334
PL - Polonia 215
FI - Finlandia 198
IT - Italia 185
SE - Svezia 177
VN - Vietnam 165
DE - Germania 136
RU - Federazione Russa 89
GB - Regno Unito 80
NL - Olanda 79
FR - Francia 77
UA - Ucraina 58
IN - India 46
CA - Canada 42
MX - Messico 40
ID - Indonesia 33
ES - Italia 32
IQ - Iraq 32
KR - Corea 31
ZA - Sudafrica 29
BW - Botswana 27
SA - Arabia Saudita 27
JP - Giappone 26
TR - Turchia 26
AR - Argentina 25
AT - Austria 25
EG - Egitto 25
GT - Guatemala 22
IE - Irlanda 22
RO - Romania 22
NP - Nepal 21
PA - Panama 21
PT - Portogallo 21
UG - Uganda 21
PR - Porto Rico 20
TJ - Tagikistan 20
AO - Angola 19
AZ - Azerbaigian 19
CO - Colombia 19
EC - Ecuador 19
LC - Santa Lucia 19
MD - Moldavia 19
TN - Tunisia 19
BZ - Belize 18
CW - ???statistics.table.value.countryCode.CW??? 18
CY - Cipro 18
DK - Danimarca 18
EE - Estonia 18
GF - Guiana Francese 18
HR - Croazia 18
TZ - Tanzania 18
BA - Bosnia-Erzegovina 17
DO - Repubblica Dominicana 17
GR - Grecia 17
KZ - Kazakistan 17
LY - Libia 17
SO - Somalia 17
TW - Taiwan 17
AU - Australia 16
BD - Bangladesh 16
BG - Bulgaria 16
CL - Cile 16
CV - Capo Verde 16
EU - Europa 16
GN - Guinea 16
PY - Paraguay 16
SK - Slovacchia (Repubblica Slovacca) 16
UZ - Uzbekistan 16
AL - Albania 15
BB - Barbados 15
BY - Bielorussia 15
CI - Costa d'Avorio 15
CM - Camerun 15
CR - Costa Rica 15
GP - Guadalupe 15
JO - Giordania 15
ME - Montenegro 15
PE - Perù 15
PK - Pakistan 15
TT - Trinidad e Tobago 15
ZM - Zambia 15
CU - Cuba 14
DZ - Algeria 14
IR - Iran 14
LB - Libano 14
MZ - Mozambico 14
RW - Ruanda 14
CZ - Repubblica Ceca 13
DM - Dominica 13
GH - Ghana 13
IL - Israele 13
JM - Giamaica 13
KE - Kenya 13
KG - Kirghizistan 13
KH - Cambogia 13
MY - Malesia 13
Totale 11.356
Salva come PNG Salva come JPEG
Città #
Woodbridge 621
Singapore 580
Ashburn 559
Chandler 553
Ann Arbor 550
Fairfield 543
Houston 506
Hong Kong 309
Cambridge 217
Wilmington 214
Seattle 193
Bytom 185
Jacksonville 160
Boardman 155
Beijing 152
Santa Clara 126
Des Moines 117
Princeton 114
Medford 103
Helsinki 83
Dong Ket 79
Los Angeles 76
Nanjing 75
Roxbury 57
San Diego 54
Padova 53
São Paulo 49
New York 36
Buffalo 33
Ho Chi Minh City 32
Jinan 30
Munich 30
Redondo Beach 29
Shenyang 27
Hebei 23
Nanchang 22
Chicago 21
Hanoi 21
Kampala 21
Gaborone 19
Guangzhou 19
Luanda 19
Panama City 19
Castries 18
Dushanbe 18
Tianjin 18
Baku 17
Cairo 17
Changsha 17
London 17
Warsaw 17
Zhengzhou 17
Guatemala City 16
Jiaxing 16
Conakry 15
Dallas 15
Dar es Salaam 15
Dublin 15
Lusaka 15
Milan 15
Cayenne 14
Hefei 14
Johannesburg 14
Kigali 14
Praia 14
Tallinn 14
Tashkent 14
Turku 14
Willemstad 14
Abidjan 13
Amman 13
Bridgetown 13
Chisinau 13
Phnom Penh 13
San José 13
Vienna 13
Andorra la Vella 12
Baghdad 12
Bamako 12
Havana 12
Jeddah 12
Montreal 12
Noumea 12
Nowon-gu 12
Roseau 12
San Francisco 12
Stockholm 12
Toronto 12
Tripoli 12
Accra 11
Amsterdam 11
Bishkek 11
Dakar 11
Harare 11
Lima 11
Limassol 11
Managua 11
Maputo 11
Nairobi 11
Nouakchott 11
Totale 7.656
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 239
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 217
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 213
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 206
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 205
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 200
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 197
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 174
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 170
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 164
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 163
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 161
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 161
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 159
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 157
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 157
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 156
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 152
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 147
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 147
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 144
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 144
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 136
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 136
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 131
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 130
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 123
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 123
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 122
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 122
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 122
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 121
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 121
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 118
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 117
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 116
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 116
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 115
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 114
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 113
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 112
NT-S100A8 effects on cell signalling. 111
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 111
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 110
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 110
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 108
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 108
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 106
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 106
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 106
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 105
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 105
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 104
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 102
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 101
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 101
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 100
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 100
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 99
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 97
Genome-wide association study identifies an early onset pancreatic cancer risk locus 97
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 96
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 96
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 94
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 93
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 92
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 92
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 92
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 91
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 91
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 90
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 89
Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. 88
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 87
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 86
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 85
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 84
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 84
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 83
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 83
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 82
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 82
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 82
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 81
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 80
Erythrocyte sedimentation rate and c-reactive protein in acute inflammation: Meta-analysis of diagnostic accuracy studies 80
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 80
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 79
Quality indicators to monitor the rejected outpatients' samples 79
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 78
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 78
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 77
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 76
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 75
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 74
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 74
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 73
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 72
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 71
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 68
Totale 11.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.329
article - articoli 16.642
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021793 0 0 0 115 45 45 34 47 99 133 104 171
2021/2022952 14 182 48 49 43 98 31 75 49 13 65 285
2022/20231.164 206 127 13 131 197 169 4 76 158 9 44 30
2023/2024592 23 70 70 49 46 63 53 65 18 36 40 59
2024/20252.522 14 128 133 121 320 54 118 199 220 96 486 633
2025/20263.037 428 766 1.135 708 0 0 0 0 0 0 0 0
Totale 12.002